Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    12090977 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
Condition: Breast Neoplasms
Interventions: Drug: Exemestane;   Dietary Supplement: Calcium carbonate;   Dietary Supplement: Vitamin D
2 Completed
Has Results
Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)
Condition: Breast Cancer
Intervention: Drug: Zometa
3 Completed Effect of Aromatase Inhibitors on Bones and Genes
Conditions: Breast Cancer;   Postmenopausal
Interventions: Procedure: Dual x-ray absorptiometry (DXA);   Procedure: Blood draw;   Behavioral: Questionnaire

Study has passed its completion date and status has not been verified in more than two years.